Hikal enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


2,496	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
9.6	9.6	13.0	12.7	26.7
681	681	762	815	748
3,167	—	—	—	—
672	672	749	802	721
₹256.47	—	—	—	—

1,880	1,880	2,025	2,002	1,881
36.2%	36.2%	37.7%	40.7%	39.8%
0.22×	—	—	—	—

1.83×	—	—	—	—
13.64×	—	—	—	—
48.58×	—	—	—	—
20.58×	—	—	—	—
1,735	1,713	1,860	1,785	2,023
232	220	328	267	257
65.2	56.6	194	149	148
—	302	280	187	315
154	154	143	−17.5	12.7
—	129	123	−38.7	−3.8
—	148	137	204	303

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

HIKAL₹202.10

Hikal Limited

· Pharma & Health

₹ CrorePeersPANACEABIO DCAL SAIPARENT INDOCO SOLARA WINDLAS INDSWFTLAB HESTERBIOMcap ₹2,496 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	2,495.9
- Cash, Equiv & ST Investments	26.7	12.7	13.0	9.6	9.6
+ Total Debt	748.0	814.7	762.3	681.1	681.1
Enterprise Value	—	—	—	—	3,167.4
Net Debt (memo)	721.2	802.0	749.3	671.5	671.5
EV per Share	—	—	—	—	256.47

Total Capital	1,881.4	2,002.4	2,024.6	1,879.9	1,879.9
Total Debt/Total Capital	39.75	40.69	37.65	36.23	36.23
Total Debt/EV	—	—	—	—	0.22

EV/Sales	—	—	—	—	1.83
EV/EBITDA	—	—	—	—	13.64
EV/EBIT	—	—	—	—	48.58
EV/Free Cash Flow	—	—	—	—	20.58
Reference Items — Trailing FY Values
Sales	2,023.0	1,784.6	1,859.8	1,712.6	1,735.0
EBITDA	257.1	267.0	328.4	220.4	232.3
EBIT	148.1	149.4	194.0	56.6	65.2
Operating Cash Flow	315.3	186.7	280.4	302.0	—
Free Cash Flow	12.7	-17.5	143.1	153.9	153.9
FCFF (free cash flow to the firm)	-3.8	-38.7	123.1	129.1	—
Capital Expenditure	302.6	204.2	137.3	148.1	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.